PMID- 35182698 OWN - NLM STAT- MEDLINE DCOM- 20220413 LR - 20221115 IS - 1873-7544 (Electronic) IS - 0306-4522 (Print) IS - 0306-4522 (Linking) VI - 488 DP - 2022 Apr 15 TI - Decreased Brain GABA Levels in Patients with Migraine Without Aura: An Exploratory Proton Magnetic Resonance Spectroscopy Study. PG - 10-19 LID - S0306-4522(22)00064-1 [pii] LID - 10.1016/j.neuroscience.2022.02.010 [doi] AB - Increasing neurophysiological studies had revealed that regional excitation-inhibition imbalance in the brain played a key role in the pathogenesis of migraine. This study aimed to explore the alterations in gamma-aminobutyric acid (GABA) and glutamate/glutamine complex (Glx) levels in the anterior cingulate gyrus (ACC) and medial prefrontal lobe (mPFC) of patients with migraine without aura (MWoA) and investigate the correlation between neurotransmitter levels and clinical indicators. A total of 28 patients with MWoA and 28 sex-, age-, and education level-matched healthy controls (HCs) underwent single-voxel proton magnetic resonance spectroscopy scanning at 3.0 Tesla. MEscher-Garwood Point RESolved Spectroscopy (MEGA-PRESS) sequence was performed to acquire the spectral data of GABA and Glx in the ACC and mPFC. The clinical indicators and anxiety-depression states of all participants were assessed. The acquired GABA signal contained the overlapping signals of macromolecules and homocarnosine, hence expressed as GABA+. The creatine (Cr) signal was applied as an endogenous reference. We observed that GABA+/Cr levels were significantly lower in ACC and mPFC of patients with MWoA than of HCs, with no significant difference in Glx levels. Negative correlations between GABA+/Cr levels and attack frequency were found in the ACC and mPFC regions of patients. These results suggested that there might be a close relationship between ACC and mPFC GABAergic neurons abnormalities and the pathophysiological mechanisms of MWoA. It might be beneficial to targeted treatment for patients with MWoA. CI - Copyright (c) 2022 IBRO. Published by Elsevier Ltd. All rights reserved. FAU - Wu, Xiaojuan AU - Wu X AD - Department of Radiology, The First Affiliated Hospital of Soochow University, No.188, Shizi Road, Suzhou City, Jiangsu Province 215000, China. FAU - Han, Shuting AU - Han S AD - Department of Radiology, The First Affiliated Hospital of Soochow University, No.188, Shizi Road, Suzhou City, Jiangsu Province 215000, China. FAU - Yang, Yang AU - Yang Y AD - Department of Radiology, The First Affiliated Hospital of Soochow University, No.188, Shizi Road, Suzhou City, Jiangsu Province 215000, China. FAU - Dai, Hui AU - Dai H AD - Department of Radiology, The First Affiliated Hospital of Soochow University, No.188, Shizi Road, Suzhou City, Jiangsu Province 215000, China. FAU - Wu, Peng AU - Wu P AD - Philips Healthcare, Shanghai 200072, China. FAU - Zhao, Hongru AU - Zhao H AD - Department of Neurology, The First Affiliated Hospital of Soochow University, No.188, Shizi Road, Suzhou City, Jiangsu Province 215000, China. Electronic address: tiantan11@163.com. FAU - Jin, Xiaohong AU - Jin X AD - Department of Pain Management, The First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Suzhou City, Jiangsu Province 215000, China. Electronic address: jinxiaohong@suda.edu.cn. FAU - Li, Yonggang AU - Li Y AD - Department of Radiology, The First Affiliated Hospital of Soochow University, No.188, Shizi Road, Suzhou City, Jiangsu Province 215000, China. Electronic address: liyonggang224@163.com. LA - eng GR - P41 EB031771/EB/NIBIB NIH HHS/United States GR - R01 EB016089/EB/NIBIB NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20220217 PL - United States TA - Neuroscience JT - Neuroscience JID - 7605074 RN - 0RH81L854J (Glutamine) RN - 3KX376GY7L (Glutamic Acid) RN - 56-12-2 (gamma-Aminobutyric Acid) RN - MU72812GK0 (Creatine) SB - IM MH - Creatine MH - Glutamic Acid MH - Glutamine MH - Gyrus Cinguli/diagnostic imaging MH - Humans MH - Magnetic Resonance Imaging MH - Magnetic Resonance Spectroscopy/methods MH - *Migraine without Aura/diagnostic imaging MH - Proton Magnetic Resonance Spectroscopy MH - gamma-Aminobutyric Acid PMC - PMC9652612 MID - NIHMS1846575 OTO - NOTNLM OT - (1)H-MRS OT - MEGA-PRESS OT - migraine without aura OT - neurotransmitter COIS- DECLARATIONS OF INTEREST None. EDAT- 2022/02/20 06:00 MHDA- 2022/04/14 06:00 PMCR- 2022/11/12 CRDT- 2022/02/19 20:09 PHST- 2021/08/29 00:00 [received] PHST- 2022/02/09 00:00 [revised] PHST- 2022/02/10 00:00 [accepted] PHST- 2022/02/20 06:00 [pubmed] PHST- 2022/04/14 06:00 [medline] PHST- 2022/02/19 20:09 [entrez] PHST- 2022/11/12 00:00 [pmc-release] AID - S0306-4522(22)00064-1 [pii] AID - 10.1016/j.neuroscience.2022.02.010 [doi] PST - ppublish SO - Neuroscience. 2022 Apr 15;488:10-19. doi: 10.1016/j.neuroscience.2022.02.010. Epub 2022 Feb 17.